TIL - Instil Bio Inc
8.055
-0.125 -1.552%
Share volume: 23,677
Last Updated: 04-24-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.22%
PREVIOUS CLOSE
CHG
CHG%
$8.18
-0.13
-0.02%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-04-2025 | 05-13-2025 | 11-13-2025 | 03-27-2026 | |
| Assets | |||||
| Total Assets | 263.567 M | 237.449 M | 211.768 M | 203.523 M | |
| Current Assets | 124.470 M | 219.264 M | 196.264 M | 191.429 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 112.096 M | 112.096 M | 112.096 M | |
| Short Term Investments | 104.510 M | 88.287 M | 73.867 M | 69.491 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 8.805 M | 15.366 M | 5.801 M | 6.638 M | |
| Total Non-current Assets | 0.000 | 7.189 M | 3.444 M | 0.000 | |
| Property Plant Equipment | 129.406 M | 162.000 K | 138.000 K | 126.000 K | |
| Other Assets | 9.691 M | 18.023 M | 15.366 M | 11.968 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 263.567 M | 237.449 M | 211.768 M | 203.523 M | |
| Total liabilities | 94.131 M | 92.537 M | 91.346 M | 89.657 M | |
| Total current liabilities | 7.896 M | 7.229 M | 5.697 M | 4.843 M | |
| Accounts Payable | 659.000 K | 286.000 K | 928.000 K | 779.000 K | |
| Other liabilities | 2.048 M | 1.081 M | 1.036 M | 8.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 84.187 M | 84.227 M | 84.613 M | 84.806 M | |
| Other liabilities | 2.048 M | 1.081 M | 1.036 M | 8.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 169.436 M | 144.912 M | 120.422 M | 113.866 M | |
| Common stock | 824.780 M | 828.679 M | 839.331 M | 840.937 M | |
| Retained earnings | -655.116 M | -683.316 M | -718.297 M | -726.488 M |